Sangamo BioSciences | SGMO - Wynik Z Tytułu Odsetek





Wynik Z Tytułu Odsetek Zmiana Data
Alnylam Pharmaceuticals USD 26.63M 2.05M 2025-12
Bayer EUR 169M 39M 2025-12
BioCryst Pharmaceuticals USD -0.13 3.59M 2024-12
Biogen USD 37.9M 700K 2026-03
BioMarin Pharmaceutical USD 22.56M 3.35M 2026-03
Compugen USD 954K 116K 2025-09
CSL USD 18M 1000K 2024-12
Gilead Sciences USD 95M 7M 2025-12
GlaxoSmithKline GBP 22M 96M 2026-03
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
J&J USD 2.14 237M 2026-03
Karyopharm Therapeutics USD -0.15 0.11 2024-12
Merck USD 69M 27M 2025-12
Pfizer USD 115M 51M 2026-03
Sanofi EUR 33M 81M 2025-12
Sarepta Therapeutics USD 8.74M 359K 2025-12
Tectonic Therapeutic USD 1.74M 217K 2024-12
Ultragenyx Pharmaceutical USD 6.51M 649K 2025-12
Vertex Pharmaceuticals USD 114.8M 7.1M 2026-03